Evoke Wealth’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $604K | Buy |
+6,921
| New | +$604K | 0.01% | 300 |
|
|
2022
Q4 | – | Sell |
-996
| Closed | -$80K | – | 591 |
|
|
2022
Q3 | $80K | Sell |
996
-257
| -21% | -$20.6K | ﹤0.01% | 446 |
|
|
2022
Q2 | $93K | Sell |
1,253
-647
| -34% | -$48K | ﹤0.01% | 422 |
|
|
2022
Q1 | $243K | Buy |
1,900
+352
| +23% | +$45K | 0.01% | 317 |
|
|
2021
Q4 | $208K | Sell |
1,548
-8
| -0.5% | -$1.08K | 0.01% | 358 |
|
|
2021
Q3 | $212K | Sell |
1,556
-192
| -11% | -$26.2K | 0.01% | 334 |
|
|
2021
Q2 | $187K | Buy |
1,748
+1,668
| +2,085% | +$178K | 0.01% | 357 |
|
|
2021
Q1 | $7K | Buy |
80
+48
| +150% | +$4.2K | ﹤0.01% | 760 |
|
|
2020
Q4 | $3K | Hold |
32
| – | – | ﹤0.01% | 813 |
|
|
2020
Q3 | $3K | Hold |
32
| – | – | ﹤0.01% | 763 |
|
|
2020
Q2 | $3K | Buy |
+32
| New | +$3K | ﹤0.01% | 781 |
|